3 results
Approved WMOCompleted
To evaluate the safety and performance of the BackBeat Moderato system.
Approved WMOCompleted
What is the prevalence of gastro-intestinal disorders and which are the determinants?
Approved WMOCompleted
To determine the activity (as measured by objective response rate by RECIST1.1) of monalizumab and trastuzumab in patients with metastatic HER2-positive breast cancer.